Topical therapy for oropharyngeal symptoms of myasthenia gravis
| Autor: | J. G. Gatein, E. J. Gibson, K. J. Goulden, B. St. J. Brown, J. M. Dooley |
|---|---|
| Rok vydání: | 1986 |
| Předmět: |
Aerosols
Ophthalmoplegia business.industry medicine.disease Acetylcholinesterase Speech Disorders Myasthenia gravis nervous system diseases chemistry.chemical_compound Neurology chemistry Pyridostigmine Anesthesia Myasthenia Gravis Blepharoptosis Humans Medicine Female Neurology (clinical) Child Deglutition Disorders business Pyridostigmine Bromide medicine.drug |
| Zdroj: | Annals of Neurology. 19:192-194 |
| ISSN: | 1531-8249 0364-5134 |
| DOI: | 10.1002/ana.410190214 |
| Popis: | Inhibitors of acetylcholinesterase are commonly used in the treatment of myasthenia gravis. We studied a patient with mainly bulbar myasthenia gravis who did not tolerate oral pyridostigmine despite a clear clinical response. Treatment with nebulized pyridostigmine reduced her symptoms without systemic side effects. This route of therapy may benefit other patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text